Boehringer opens China tech center

Advanced Search

The story appears on

Page A10

July 3, 2020

GET this page in PDF

Free for subscribers

View shopping cart

Boehringer opens China tech center

By Ding Yining | 00:28 UTC+8 July 3, 2020 |

Print Edition

German pharmaceutical company Boehringer Ingelheim yesterday unveiled its External Innovation Hub in Shanghai.

In the next five years, the company will invest 451 million euros (US$507.9 million) in China in clinical research, production expansion and other research partnerships.

“Boehringer Ingelheim will continue to increase investment in China, including setting up the External Innovation Hub.

“The hub will become one of Boehringer Ingelheim’s strategic pillars,” said Felix Gutsche, president and CEO of Boehringer Ingelheim China.

The company expects to have 71 new products approved in China by 2030.

“COVID-19 has highlighted the importance of digital services.

“And our latest digital initiative hopes to integrate all the methodology and technology with real business needs,” he told Shanghai Daily.

“China is the first market to see business rebound after the coronavirus outbreak.”

Business

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Boehringer opens China tech center

Email this to your friend